Canaccord Genuity Keeps Their Buy Rating on Paladin Energy Ltd (PALAF)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bullen covers the Energy sector, focusing on stocks such as Amplitude Energy, Paladin Energy Ltd, and Bannerman Energy. According to TipRanks, Bullen has an average return of 2.1% and a 45.99% success rate on recommended stocks.
In addition to Canaccord Genuity, Paladin Energy Ltd also received a Buy from Morgan Stanley's Shannon Sinha in a report issued on July 24. However, on the same day, J.P. Morgan upgraded Paladin Energy Ltd (Other OTC: PALAF) to a Hold.
PALAF market cap is currently $1.92B and has a P/E ratio of -125.87.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Canaccord Genuity Reiterates Buy Rating on Fractyl Health (GUTS)
Fractyl Health, Inc. (NASDAQ:GUTS) is one of the 11 Best New Penny Stocks to Buy Right Now. On July 18, Canaccord Genuity reiterated its 'Buy' rating on Fractyl Health, Inc. (NASDAQ:GUTS) with a price target of $12. This decision came after the company had shared new data from its Phase 3 trial of its lead product candidate, Revita. A medical laboratory surrounded by advanced equipment, symbolizing the company's cutting-edge innovation in healthcare. Canaccord Genuity had follow-up discussions with several physicians following the data presented by Fractyl Health, Inc. (NASDAQ:GUTS) from the open-label group of its ongoing Phase 3 trial for Revita in weight maintenance at the American Diabetes Association meeting. These physicians who were consulted by the investment firm were all from large academic hospitals in the US. The physicians had different opinions on the mechanism behind the Revita procedure and the potential market size. However, they all agreed that controlled data is needed to fully assess the clinical profile. The physicians said the main concern is the durability of the effect. Canaccord pointed out that even conservative market share estimates from the physicians surpassed the firm's current modeling expectations. Canaccord Genuity expects Revita to reach 1% peak penetration in the weight maintenance population with a 60% probability of success. The investment firm projects that peak sales could reach $400 million in 2031. Fractyl Health, Inc. (NASDAQ:GUTS) is a metabolic therapeutics company focused on pursuing therapies that target root causes of obesity and type 2 diabetes. While we acknowledge the potential of GUTS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
30 minutes ago
- Yahoo
Boeing-built X-37B spaceplane set for eighth mission
The Boeing (BA)-built X-37B Orbital Test Vehicle s preparing to launch its eighth mission from Florida's Space Coast, with liftoff scheduled no earlier than August 21. This milestone comes less than six months after the successful completion of OTV-7, Boeing said. 'With each successive flight, the X-37B has demonstrated adaptability and flexibility by hosting diverse experiments and pioneering new orbital regimes,' said Michelle Parker, vice president of Boeing Space Mission Systems. 'This mission continues that legacy by fielding cutting-edge technologies that advance our nation's space capability and improve the resilience of future architectures.' Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on BA: Disclaimer & DisclosureReport an Issue Boeing (BA) Is About to Report Q2 Earnings. Here's What to Expect U.S. executives to visit China this week, Reuters reports Bangladesh ordered 25 Boeing planes in effort to lower tariffs, Reuters says Boeing prepares for strike at St. Louis defense hub, Bloomberg says Trump Trade: Trump sees '50/50′ chance of making trade deal with EU
Business Wire
2 hours ago
- Business Wire
Electromed, Inc. to Participate in the Canaccord Genuity 45 th Annual Growth Conference
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. ('Electromed' or the 'Company') (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Company management will participate in the Canaccord Genuity 45 th Annual Growth Conference, which will be held August 12-14, 2025 in Boston, MA. Electromed President and Chief Executive Officer Jim Cunniff, and Chief Financial Officer Brad Nagel will present on Tuesday, August 12 at 12:30 pm ET. Interested parties may access a live webcast of the presentation using the following link: Electromed CG Presentation. The link will also be posted on the Electromed Investor Relations website under Events & Presentations. Institutional investors may request one-on-one meetings through Canaccord Genuity. About Electromed, Inc. Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest ® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at
